Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$69.23 - $79.09 $4.28 Million - $4.89 Million
-61,786 Reduced 54.11%
52,391 $3.94 Million
Q2 2023

Aug 14, 2023

SELL
$45.44 - $71.21 $778,887 - $1.22 Million
-17,141 Reduced 13.05%
114,177 $8.13 Million
Q1 2023

May 15, 2023

SELL
$43.88 - $52.48 $5,133 - $6,140
-117 Reduced 0.09%
131,318 $6.58 Million
Q4 2022

Feb 14, 2023

SELL
$40.82 - $57.75 $79,476 - $112,439
-1,947 Reduced 1.46%
131,435 $5.74 Million
Q3 2022

Nov 14, 2022

SELL
$46.84 - $58.49 $155,134 - $193,718
-3,312 Reduced 2.42%
133,382 $7.1 Million
Q2 2022

Aug 15, 2022

SELL
$34.86 - $63.77 $251,898 - $460,802
-7,226 Reduced 5.02%
136,694 $6.21 Million
Q1 2022

May 16, 2022

BUY
$44.33 - $57.82 $75,405 - $98,351
1,701 Added 1.2%
143,920 $8.32 Million
Q4 2021

Feb 14, 2022

BUY
$40.27 - $56.99 $1.38 Million - $1.96 Million
34,338 Added 31.83%
142,219 $6.32 Million
Q3 2021

Nov 15, 2021

SELL
$47.43 - $84.23 $84,235 - $149,592
-1,776 Reduced 1.62%
107,881 $5.2 Million
Q2 2021

Aug 16, 2021

SELL
$73.06 - $97.7 $15,780 - $21,103
-216 Reduced 0.2%
109,657 $9.3 Million
Q1 2021

May 17, 2021

SELL
$70.43 - $97.42 $1.06 Million - $1.47 Million
-15,068 Reduced 12.06%
109,873 $9.22 Million
Q4 2020

Feb 16, 2021

SELL
$48.9 - $75.26 $918,782 - $1.41 Million
-18,789 Reduced 13.07%
124,941 $9.4 Million
Q3 2020

Nov 16, 2020

SELL
$37.23 - $50.97 $96,872 - $132,623
-2,602 Reduced 1.78%
143,730 $7.12 Million
Q2 2020

Aug 14, 2020

BUY
$28.78 - $46.83 $1.41 Million - $2.29 Million
48,926 Added 50.23%
146,332 $5.62 Million
Q1 2020

May 15, 2020

BUY
$25.53 - $70.14 $734,983 - $2.02 Million
28,789 Added 41.96%
97,406 $3.01 Million
Q4 2019

Feb 14, 2020

SELL
$54.18 - $65.64 $159,072 - $192,719
-2,936 Reduced 4.1%
68,617 $3.74 Million
Q3 2019

Nov 14, 2019

BUY
$58.58 - $83.91 $4.19 Million - $6 Million
71,553 New
71,553 $4.47 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.48B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.